ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
CELL THERAPEUTICS
(NQ:
CTIC
)
1.265
USD
-0.065 (-4.89%)
Streaming Delayed Price
/ Updated:
1:22 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
659,845
Open
1.300
Bid (Size)
1.260 (10900)
Ask (Size)
1.270 (3800)
Prev. Close
1.330
Today's Range
1.240 - 1.300
52wk Range
1.020 - 3.939
Shares Outstanding
112,633,915
Dividend Yield
N/A
Featured News
More News
The Nasdaq Now: Zynga Plunges, Drags Facebook Along With It
October 05, 2012
MINYANVILLE ORIGINAL Powered by expectations-beating job growth numbers for September US equities inched up in intra-Friday trading. The Nasdaq Composite (INDEXNASDAQ:.IXIC) is up 0.09% to 3 151.99...
Read More
from
Minyanville Headlines
Friday’s biggest gaining and declining stocks
October 05, 2012
MarketWatch’s daily rundown of shares poised to make sizable moves in the U.S. stock market.
Read More
category
ZNGA
,
Biotechnology
,
Retail
, and 16 more.
from
MarketWatch
Featured News
Read More
Tuesday’s biggest gaining and declining stocks
October 02, 2012
category
Biotechnology
,
Retail
,
CTIC
, and 16 more.
from
MarketWatch
Tuesday’s top gaining and declining stocks
September 11, 2012
category
Computer Software
,
SQNM
,
Biotechnology
, and 16 more.
from
MarketWatch
Tuesday’s biggest gaining and declining stocks
September 04, 2012
category
Computer Software
,
Biotechnology
,
VRX
, and 18 more.
from
MarketWatch
More News
Read More
Preliminary Russell 3000 Addition Pushing Stocks Around
June 17, 2013
from
StreetInsider.com News Articles
StreetInsider.com Pre-Open Movers 6/17: (KNDI) (NFLX) (AMD) Higher; (FOLD) (TEX) (ARMH) Lower (more...)
June 17, 2013
from
StreetInsider.com News Articles
CTI Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients with Myelofibrosis
June 17, 2013
from
PR Newswire
New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment
June 17, 2013
from
PR Newswire
Cell Therapeutics to Join Russell 3000® and Russell Global Indexes
June 17, 2013
from
PR Newswire
StockCall Pre-Market Review on ACAD, DNDN, MDVN, CTIC, and SRPT
June 13, 2013
from
ACCESSWIRE
CTI Announces Data Presentations at the 18th Congress of the European Hematology Association
June 11, 2013
from
PR Newswire
Faruqi & Faruqi, LLP Launches An Investigation Against Cell Therapeutics, Inc. (CTIC) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
June 05, 2013
from
Business Wire News Releases
CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
June 01, 2013
from
PR Newswire
Investors look to Lighten Up on Shares of Cell Therapeutics, Shares Down 5.2% (CTIC)
May 22, 2013
from
Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
The Future of Android Looks More Like Apple Inc.
Mike Schuster
2
The Waning Integrity of US Financial Markets
Todd Harrison
3
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
4
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
5
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster
See All Articles
»